CMV IgG/IgM Antibody Rapid Test
- UID
- MFG/IVD/2023/000113_dee4969a7311f24b4c2bef9cc1654ebe_829e3dab6602e0858a44e004f17c761a
- Device class
- Class B
- Brand name
- Chimera
- License holder
- CHIMERA BIOTECH PRIVATE LIMITED
- Approving authority
- South Delhi Division
- Product information
- The Chimera® CMV IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of the cytomegalovirus IgM/G antibody in serum /plasma. It is used as an aid in the diagnostic of past infection and epidemiological investigation
CMV IgG/IgM Antibody Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_dee4969a7311f24b4c2bef9cc1654ebe_829e3dab6602e0858a44e004f17c761a. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.